Open access · CC-BY
via OpenAlex
Direct in vivo reprogramming to relieve tissue ischemia via induced vasculogenesis
Mervin C. Yöder, Chandan K. Sen
Molecular Therapy · 2025 · ▲ 1 citations
Deregulated nutrient-sensing
Partial reprogramming (OSK)
Cell culture / in vitro
Human
Preclinical / animal
In vitro
Review
Abstract
There is an ongoing need for innovative cell and regenerative medicine therapies to promote vascular repair and regeneration to meet the growing global health concern of ischemic cardiovascular diseases. Direct reprogramming of somatic cells into an induced pluripotent state caused scientists to reconsider prior theories of cell differentiation and develop approaches to directly reprogram cells in vivo into other states or fates to adaptively replace cells lost to aging or disease. While direct in vivo reprogramming of fibroblast to cardiomyocytes, neurons, or pancreatic beta islet cell states has been studied since 2008, direct in vivo reprogramming of fibroblasts into induced vasculogenic cells was not reported until 2017. This review provides a brief overview of the field of in vitro direct reprogramming of fibroblasts into induced endothelial cells over the past decade and identifies key similarities and differences in approaches. The primary focus of this review is to discuss in detail 4 published reports of direct in vivo reprogramming of fibroblasts into vasculogenic cell states and identify a series of questions for future studies that will clarify the reprogrammed cells and potential for using these approaches for translation into larger preclinical models or human subjects.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1016/j.ymthe.2025.08.013
- Canonical
- link ↗
- Fetched
- 2026-11-09 MST
Cite this
APA
Yöder, M.C., & Sen, C.K. (2025). Direct in vivo reprogramming to relieve tissue ischemia via induced vasculogenesis. <em>Molecular Therapy</em>. https://doi.org/10.1016/j.ymthe.2025.08.013
Vancouver
Yöder MC, Sen CK. Direct in vivo reprogramming to relieve tissue ischemia via induced vasculogenesis. Molecular Therapy. 2025. doi:10.1016/j.ymthe.2025.08.013.
BibTeX
@article{mervin2025Direct,
title = {Direct in vivo reprogramming to relieve tissue ischemia via induced vasculogenesis},
author = {Mervin C. Yöder and Chandan K. Sen},
journal = {Molecular Therapy},
year = {2025},
doi = {10.1016/j.ymthe.2025.08.013},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Research Square 2022
Preprint · CC-BY
Metadichol, a natural ligand for the expression of Yamanaka reprogramming factors in somatic and primary cancer cell lines
BioEssays 2023
Open access · CC-BY
Epigenetic rejuvenation by partial reprogramming
Frontiers in Cellular Neuroscience 2018
Open access · CC-BY
Potentials of Cellular Reprogramming as a Novel Strategy for Neuroregeneration
The Journals of Gerontology Series A 2016
Open access · CC0
Moving Geroscience Into Uncharted Waters: Table 1.
Stem Cell Reports 2023
Open access · CC-BY
Generation of canine induced pluripotent stem cells under feeder-free conditions using Sendai virus vector encoding six canine reprogramming factors
Journal of Neuroscience Research 2023
Open access · CC-BY